{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Ayurveda", "COVID-19", "IL6", "Immunity.", "Immunomodulatory", "NLR", "Picrorhiza kurroa, AEV01", "SARS-COV-2", "TNF-Alpha"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38320447", "DateRevised": {"Year": "2024", "Month": "03", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["100860", "10.1016/j.jaim.2023.100860", "S0975-9476(23)00177-8"], "ArticleDate": [{"Year": "2024", "Month": "02", "Day": "06"}], "Journal": {"ISSN": "0975-9476", "JournalIssue": {"Volume": "15", "Issue": "1", "PubDate": {"Year": "2024", "Season": "Jan-Feb"}}, "Title": "Journal of Ayurveda and integrative medicine", "ISOAbbreviation": "J Ayurveda Integr Med"}, "ArticleTitle": "A randomized, placebo controlled, double blinded, parallel group clinical study to evaluate the efficacy and safety of AEV01 along with standard care for elderly patients with mild COVID-19.", "Pagination": {"StartPage": "100860", "MedlinePgn": "100860"}, "Abstract": {"AbstractText": ["While several drugs are in the pipeline for treatment of various grades of COVID-19 disease, none of them have shown promise until now. Medicinal plants are crucial in developing and developed countries for their primary and basic health needs owing to better tolerability, superior compatibility with human body and having lesser side effects.", "To test adjuvant effect of AEV01, a patented herbal extract of kutki (Picrorhiza kurroa), in mild COVID19 in elderly patients at risk of complications and aging immunity.", "A prospective, phase 3, randomized, multicentric, placebo controlled double blinded parallel group interventional trial was conducted in elderly patients aged above 50 years diagnosed as COVID-19 with mild symptoms. 70 patients were randomized into two groups to receive AEV01 capsule (100\u00a0mg) and placebo respectively thrice daily for 30 days along with standard care of treatment as per national (WHO/ICMR) guidelines in both the groups. Clinical improvement timelines and corresponding scores using 8-point ordinal scale and NEWS were assessed for efficacy and safety of AEV01 in COVID-19 patients.", "AEV01 group showed a significant improvement (p\u00a0=\u00a00.0001) in the normalization of the SpO<sub>2</sub> rate and relief from cough. There was also significant difference in time to recovery, with patients in the AEV01 drug treated group recovering in 4.5 days as compared to Placebo in 9.1 days. ESR, LDH, serum ferritin, Neutrophil-Lymphocyte ratio (NLR), TNF- alpha, IL-6 and CD4 cell counts, which are considered as prognostic markers in COVID-19 infected patients, showed a significant improvement in patients treated with AEV01. The AEV01 drug treated group showed significant clinical improvement in the 8-point ordinal scale severity rating and National Early Warning Score (NEW) Score from day 3 onwards which continued up to end of study.", "AEV01 has shown a significant improvement in clinical and laboratory parameters. There was also reduction in the progression of the COVID-19 disease in unvaccinated elderly patients from mild to moderate when treated at an earlier stage."], "CopyrightInformation": "Copyright \u00a9 2023 The Authors. Published by Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Pondicherry Institute of Medical Sciences, Pondicherry, India."}], "LastName": "Balan", "ForeName": "Aravinda Kumar", "Initials": "AK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Government Vellore Medical College, Vellore, India."}], "LastName": "Kannan", "ForeName": "Ramesh", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dhanwanthralaya Ayurveda Speciality Hospital, Chennai, Tamilnadu, India."}], "LastName": "Muralikumar", "ForeName": "Vanitha", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Raja Rajeswari Medical College & Hospital, Bengaluru, India."}], "LastName": "Annam", "ForeName": "Vamseedhar", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Sri Venkateshwaraa Medical College Hospital and Research Centre, India."}], "LastName": "Murugesan", "ForeName": "Sakthi Balan", "Initials": "SB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Astrel Genome Ltd, Hyderabad, India."}], "LastName": "Sekhar", "ForeName": "M M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Astrel Genome Ltd, Hyderabad, India."}], "LastName": "Medasani", "ForeName": "Renu", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Ayurveda Integr Med", "NlmUniqueID": "101551404", "ISSNLinking": "0975-9476"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Pedrea\u00f1ez A., Mosquera-Sulbaran J., Mu\u00f1oz N. SARS-CoV-2 infection represents a high risk for the elderly: analysis of pathogenesis. Arch Virol. 2021;166:1565\u20131574. doi: 10.1007/s00705-021-05042-w.", "ArticleIdList": ["10.1007/s00705-021-05042-w", "PMC7982908", "33751241"]}, {"Citation": "Gustafson C.E., Kim C., Weyand C.M., Goronzy J.J. Influence of immune aging on vaccine responses. J Allergy Clin Immunol. 2020;145:1309\u20131321. doi: 10.1016/j.jaci.2020.03.017.", "ArticleIdList": ["10.1016/j.jaci.2020.03.017", "PMC7198995", "32386655"]}, {"Citation": "AdvisoryforElderlyPopulation, n.d. [Internet]. Available from: https://www.mohfw.gov.in/pdf/AdvisoryforElderlyPopulation.pdf (accessed on August 2023)."}, {"Citation": "Yang Y., Islam M.S., Wang J., Li Y., Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Int J Biol Sci. 2020;16:1708\u20131717. doi: 10.7150/ijbs.45538.", "ArticleIdList": ["10.7150/ijbs.45538", "PMC7098036", "32226288"]}, {"Citation": "Lythgoe M.P., Middleton P. Ongoing clinical trials for the management of the COVID-19 pandemic. Trends Pharmacol Sci. 2020;41:363\u2013382. doi: 10.1016/j.tips.2020.03.006.", "ArticleIdList": ["10.1016/j.tips.2020.03.006", "PMC7144665", "32291112"]}, {"Citation": "Ahmad S., Zahiruddin S., Parveen B., Basist P., Parveen A., Gaurav null, Parveen R., Ahmad M. Indian medicinal plants and formulations and their potential against COVID-19-preclinical and clinical research. Front Pharmacol. 2020;11 doi: 10.3389/fphar.2020.578970.", "ArticleIdList": ["10.3389/fphar.2020.578970", "PMC7962606", "33737875"]}, {"Citation": "Chopra R.N., Nayar S.L., Chopra I.C., Asolkar L.V., Kakkar K.K., Chakre O.J. In: Council of scientific & industrial research. Asolkar L.V., Kakkar K.K., Chakre O.J., editors. Publications & Informations Directorate; New Delhi: 1992. Glossary of Indian medicinal plants. Suppl. 2, Pt. 1: with active principles, (A - K)(1965-81)/by."}, {"Citation": "Kumar, V., Singh, S.B., Singh, S., n.d. Pharmacological perspectives of ayurvedic herbs viz. Alstonia scholaris L., Picrorhiza kurroa, swertia chirata and Caesalpinia crista against COVID- 19: a mini-review. Mini-Reviews Org Chem 18, 841\u2013849."}, {"Citation": "Puri A., Saxena R.P., Sumati, Guru P.Y., Kulshreshtha D.K., Saxena K.C., Dhawan B.N. Immunostimulant activity of Picroliv, the iridoid glycoside fraction of Picrorhiza kurroa, and its protective action against Leishmania donovani infection in hamsters. Planta Med. 1992;58:528\u2013532.", "ArticleIdList": ["1484891"]}, {"Citation": "Sultan P., Jan A., Pervaiz Q. Phytochemical studies for quantitative estimation of iridoid glycosides in Picrorhiza kurroa Royle. Bot Stud. 2016;57:7. doi: 10.1186/s40529-016-0121-2.", "ArticleIdList": ["10.1186/s40529-016-0121-2", "PMC5430581", "28597416"]}, {"Citation": "API  . 2023. http://www.ayurveda.hu/api/API-Vol-2.pdf (The ayurvedic Pharmacopoeia of India). Vol-2.pdf, n.d. 11. Available from: August."}, {"Citation": "Raut A., Dhami-Shah H., Phadke A., Shindikar A., Udipi S., Joshi J., Vaidya R., Vaidya A.D.B. Picrorhiza kurroa, Royle ex Benth:Traditional uses, phytopharmacology, and translational potential in therapy of fatty liver disease. J Ayurveda Integr Med. 2023;14 doi: 10.1016/j.jaim.2022.100558.", "ArticleIdList": ["10.1016/j.jaim.2022.100558", "PMC10105242", "35659739"]}, {"Citation": "Rubio-Rivas M., Mora-Luj\u00e1n J.M., Formiga F., Ar\u00e9valo-Ca\u00f1as C., Lebr\u00f3n Ramos J.M., Villalba Garc\u00eda M.V., Fonseca Aizpuru E.M., D\u00edez-Manglano J., Arnalich Fern\u00e1ndez F., Romero Cabrera J.L., Garc\u00eda Garc\u00eda G.M., Pesqueira Fontan P.M., Vargas N\u00fa\u00f1ez J.A., Freire Castro S.J., Loureiro Amigo J., Pascual P\u00e9rez M. de L.R., Alcal\u00e1 Pedrajas J.N., Encinas-S\u00e1nchez D., Mella P\u00e9rez C., Ena J., Gracia Guti\u00e9rrez A., Esteban Giner M.J., Varona J.F., Mill\u00e1n N\u00fa\u00f1ez-Cort\u00e9s J., Casas-Rojo J.-M. vol. 37. J Gen Intern Med; 2022. SEMI-COVID-19 network; pp. 1980\u20131987. (WHO ordinal scale and inflammation risk categories in COVID-19. Comparative study of the severity scales).", "ArticleIdList": ["10.1007/s11606-022-07511-7", "PMC8992782", "35396659"]}, {"Citation": "Mahmood S., Hussain S., Tabassum S., Malik F., Riaz H. Comparative phytochemical, hepatoprotective and antioxidant activities of various samples of Swertia Chirayita collected from various cities of Pakistan. Pak J Pharm Sci. 2014;27:1975\u20131983.", "ArticleIdList": ["25362620"]}, {"Citation": "Garibaldi B.T., Wang K., Robinson M.L., Zeger S.L., Bandeen-Roche K., Wang M.-C., Alexander G.C., Gupta A., Bollinger R., Xu Y. Comparison of time to clinical improvement with vs without Remdesivir treatment in hospitalized patients with COVID-19. JAMA Netw Open. 2021;4 doi: 10.1001/jamanetworkopen.2021.3071.", "ArticleIdList": ["10.1001/jamanetworkopen.2021.3071", "PMC7991975", "33760094"]}, {"Citation": "Guan W., Ni Z., Hu Yu, Liang W., Ou C., He J., Liu L., Shan H., Lei C., Hui D.S.C., Du B., Li L., Zeng G., Yuen K.-Y., Chen R., Tang C., Wang T., Chen P., Xiang J., Li S., Wang Jin-lin, Liang Z., Peng Y., Wei L., Liu Y., Hu Ya-hua, Peng P., Wang Jian-ming, Liu J., Chen Z., Li G., Zheng Z., Qiu S., Luo J., Ye C., Zhu S., Zhong N. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708\u20131720. doi: 10.1056/NEJMoa2002032.", "ArticleIdList": ["10.1056/NEJMoa2002032", "PMC7092819", "32109013"]}, {"Citation": "Cr P., Vanidassane I., Pownraj D., Kandasamy R., Basheer A. National Early Warning Score 2 (NEWS2) to predict poor outcome in hospitalised COVID-19 patients in India. PLoS One. 2021;16 doi: 10.1371/journal.pone.0261376.", "ArticleIdList": ["10.1371/journal.pone.0261376", "PMC8673675", "34910789"]}, {"Citation": "Kumar R., Gupta Y.K., Singh S., Raj A. Anti-inflammatory effect of Picrorhiza kurroa in experimental models of inflammation. Planta Med. 2016;82:1403\u20131409. doi: 10.1055/s-0042-106304.", "ArticleIdList": ["10.1055/s-0042-106304", "27163229"]}, {"Citation": "Maurya V.K., Kumar S., Bhatt M.L.B., Saxena S.K. Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection. J Biomol Struct Dyn. 2020:1\u201317. doi: 10.1080/07391102.2020.1832577.", "ArticleIdList": ["10.1080/07391102.2020.1832577", "PMC7597308", "33073699"]}, {"Citation": "Jeong H.-J., Koo H.-N., Na H.-J., Kim M.-S., Hong S.-H., Eom J.-W., Kim K.-S., Shin T.-Y., Kim H.-M. Inhibition of TNF-alpha and IL-6 production by Aucubin through blockade of NF-kappaB activation RBL-2H3 mast cells. Cytokine. 2002;18:252\u2013259. doi: 10.1006/cyto.2002.0894.", "ArticleIdList": ["10.1006/cyto.2002.0894", "12161100"]}, {"Citation": "Pandey B.L., Das P.K. Immunopharmacological studies on Picrorhiza kurroa Royle-ex-Benth. Part IV: cellular mechanisms of anti-inflammatory action. Indian J Physiol Pharmacol. 1989;33:28\u201330.", "ArticleIdList": ["2544530"]}, {"Citation": "Win N.N., Kodama T., Lae K.Z.W., Win Y.Y., Ngwe H., Abe I., Morita H. Bis-iridoid and iridoid glycosides: viral protein R inhibitors from Picrorhiza kurroa collected in Myanmar. Fitoterapia. 2019;134:101\u2013107. doi: 10.1016/j.fitote.2019.02.016.", "ArticleIdList": ["10.1016/j.fitote.2019.02.016", "30794917"]}, {"Citation": "Gupta A., Khajuria A., Singh J., Bedi K.L., Satti N.K., Dutt P., Suri K.A., Suri O.P., Qazi G.N. Immunomodulatory activity of biopolymeric fraction RLJ-NE-205 from Picrorhiza kurroa. Int Immunopharm. 2006;6:1543\u20131549. doi: 10.1016/j.intimp.2006.05.002.", "ArticleIdList": ["10.1016/j.intimp.2006.05.002", "16919826"]}, {"Citation": "Sidiq T., Khajuria A., Suden P., Sharma R., Singh S., Suri K.A., Satti N.K., Johri R.K. Possible role of macrophages induced by an irridoid glycoside (RLJ-NE-299A) in host defense mechanism. Int Immunopharm. 2011;11:128\u2013135. doi: 10.1016/j.intimp.2010.10.017.", "ArticleIdList": ["10.1016/j.intimp.2010.10.017", "21074614"]}, {"Citation": "Morikawa T., Nakanishi Y., Inoue N., Manse Y., Matsuura H., Hamasaki S., Yoshikawa M., Muraoka O., Ninomiya K. Acylated iridoid glycosides with hyaluronidase inhibitory activity from the rhizomes of Picrorhiza kurroa Royle ex Benth. Phytochemistry. 2020;169 doi: 10.1016/j.phytochem.2019.112185.", "ArticleIdList": ["10.1016/j.phytochem.2019.112185", "31678786"]}, {"Citation": "Liu J., Liu Y., Xiang P., Pu L., Xiong H., Li C., Zhang M., Tan J., Xu Y., Song R., Song M., Wang L., Zhang W., Han B., Yang L., Wang Xiaojing, Zhou G., Zhang T., Li B., Wang Y., Chen Z., Wang Xianbo. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18:206. doi: 10.1186/s12967-020-02374-0.", "ArticleIdList": ["10.1186/s12967-020-02374-0", "PMC7237880", "32434518"]}, {"Citation": "Zhang H., Wu T. CD4+T, CD8+T counts and severe COVID-19: a meta-analysis. J Infect. 2020;81:e82\u2013e84. doi: 10.1016/j.jinf.2020.06.036.", "ArticleIdList": ["10.1016/j.jinf.2020.06.036", "PMC7305716", "32569604"]}, {"Citation": "Pallotto C., Suardi L.R., Esperti S., Tarquini R., Grifoni E., Meini S., Valoriani A., Di Martino S., Cei F., Sisti E., Piani F., Botta A., Salomoni E., Baragli F., Blanc P. Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study. Infectious Diseases. 2020;52:675\u2013677. doi: 10.1080/23744235.2020.1778178.", "ArticleIdList": ["10.1080/23744235.2020.1778178", "32543971"]}, {"Citation": "Wang F., Nie J., Wang H., Zhao Q., Xiong Y., Deng L., Song S., Ma Z., Mo P., Zhang Y. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis. 2020;221:1762\u20131769. doi: 10.1093/infdis/jiaa150.", "ArticleIdList": ["10.1093/infdis/jiaa150", "PMC7184346", "32227123"]}, {"Citation": "Marusina A.I., Ono Y., Merleev A.A., Shimoda M., Ogawa H., Wang E.A., Kondo K., Olney L., Luxardi G., Miyamura Y., Yilma T.D., Villalobos I.B., Bergstrom J.W., Kronenberg D.G., Soulika A.M., Adamopoulos I.E., Maverakis E. CD4+ virtual memory: antigen-inexperienced T cells reside in the na\u00efve, regulatory, and memory T cell compartments at similar frequencies, implications for autoimmunity. J Autoimmun. 2017;77:76\u201388. doi: 10.1016/j.jaut.2016.11.001.", "ArticleIdList": ["10.1016/j.jaut.2016.11.001", "PMC6066671", "27894837"]}, {"Citation": "Xie G., Ding F., Han L., Yin D., Lu H., Zhang M. The role of peripheral blood eosinophil counts in COVID-19 patients. Allergy. 2021;76:471\u2013482. doi: 10.1111/all.14465.", "ArticleIdList": ["10.1111/all.14465", "PMC7323233", "32562554"]}]}], "History": [{"Year": "2022", "Month": "2", "Day": "12"}, {"Year": "2023", "Month": "11", "Day": "21"}, {"Year": "2023", "Month": "12", "Day": "5"}, {"Year": "2024", "Month": "2", "Day": "7", "Hour": "0", "Minute": "43"}, {"Year": "2024", "Month": "2", "Day": "7", "Hour": "0", "Minute": "42"}, {"Year": "2024", "Month": "2", "Day": "6", "Hour": "18", "Minute": "8"}, {"Year": "2024", "Month": "2", "Day": "6"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38320447", "PMC10945437", "10.1016/j.jaim.2023.100860", "S0975-9476(23)00177-8"]}}]}